Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1940272 AUSTIN, TX
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,211,921
+$8,146,909 QoQ
Shares Held
283,982
-16.1% QoQ
Ownership
0.322%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#49
of 266 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. SYRE ranks #12 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in SYRE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,211,921 283,982
2026-03-31 $17,065,012 338,323
2025-12-31 $1,115,510 34,051
2025-09-30 $570,694 34,051
2025-06-30 $509,743 34,051
2025-03-31 $242,557 15,033
2024-09-30 $369,389 12,560
2024-06-30 $827,081 35,180
2024-03-31 $1,877,535 49,500
2023-12-31 $138,588 6,440